siRNA therapy improves multimodality imaging in hereditary transthyretin cardiac amyloidosis: a case report

QJM. 2024 Apr 12;117(4):304-306. doi: 10.1093/qjmed/hcae005.

Authors

T Awaya¹, J Endo², R Iijima¹, M Shimoda³, M Moroi¹

Affiliations

¹ Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
² Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
³ Department of Pathology, Keio University School of Medicine, Tokyo, Japan.

PMID: 38229248
DOI: 10.1093/qjmed/hcae005

No abstract available

Publication types

Case Reports

MeSH terms

Amyloid Neuropathies, Familial* / diagnostic imaging
Amyloid Neuropathies, Familial* / genetics
Amyloid Neuropathies, Familial* / therapy
Heart
Humans
Prealbumin* / genetics
RNA, Small Interfering

Substances

RNA, Small Interfering
Prealbumin

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related